Literature DB >> 25982811

Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome.

Gagan Fervaha1, George Foussias2, Ofer Agid2, Gary Remington2.   

Abstract

Negative symptoms, in particular motivational deficits, are reported as impediments to functional recovery in patients with schizophrenia. This study examined the prevalence of motivational deficits in patients early in the illness, and the impact these deficits have on community functioning. Patients with schizophrenia between the ages of 18 and 35years, and within 5years of initiating antipsychotic treatment were included in the present investigation (N=166). The impact of motivation and cognition on concurrent and longitudinal functioning was evaluated. Motivational impairments were found in more than 75% of participants, and were not associated with receipt of social support. These deficits served as the most robust and reliable predictor of functional outcome, while neurocognition demonstrated significantly weaker associations with outcome. When considered together, motivational deficits demonstrated a reliable link with concurrent and longitudinal functioning, with cognition not offering any independent predictive value. Moreover, motivation was found to mediate the relationship between cognition and outcome. Changes in motivation were linked to changes in functioning; however, this was not the case for changes in cognitive performance. Motivation emerged as a significant predictor of functioning even after selected demographic and clinical characteristics (e.g., positive symptoms) were accounted for. These data indicate that motivational deficits are prevalent in patients with schizophrenia, even in the early stages of the illness, and these deficits stand as one of the most robust barriers to people with schizophrenia achieving functional recovery. Greater understanding of the mechanisms underlying these deficits is critical to effective treatment innovation.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amotivation; Apathy; Avolition; Negative symptoms; Neurocognition; Psychosis; Real-world functional outcome; Social functioning

Mesh:

Substances:

Year:  2015        PMID: 25982811     DOI: 10.1016/j.schres.2015.04.040

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  34 in total

1.  Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.

Authors:  Samantha E Yohn; Daniela Alberati; Merce Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2017-01-12       Impact factor: 4.530

2.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

3.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

4.  Apathy Is Associated With Ventral Striatum Volume in Schizophrenia Spectrum Disorder.

Authors:  Robert M Roth; Matthew A Garlinghouse; Laura A Flashman; Nancy S Koven; J Cara Pendergrass; James C Ford; Thomas W McAllister; Andrew J Saykin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2016-02-22       Impact factor: 2.198

5.  Metacognition Is Necessary for the Emergence of Motivation in People With Schizophrenia Spectrum Disorders: A Necessary Condition Analysis.

Authors:  Lauren Luther; Kelsey A Bonfils; Ruth L Firmin; Kelly D Buck; Jimmy Choi; Giancarlo Dimaggio; Raffaele Popolo; Kyle S Minor; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2017-12       Impact factor: 2.254

6.  Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.

Authors:  Fernando Caravaggio; Gagan Fervaha; Yusuke Iwata; Eric Plitman; Jun Ku Chung; Shinichiro Nakajima; Wanna Mar; Philip Gerretsen; Julia Kim; M Mallar Chakravarty; Benoit Mulsant; Bruce Pollock; David Mamo; Gary Remington; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2017-11-07       Impact factor: 3.485

7.  Impaired Expected Value Computations in Schizophrenia Are Associated With a Reduced Ability to Integrate Reward Probability and Magnitude of Recent Outcomes.

Authors:  Dennis Hernaus; Michael J Frank; Elliot C Brown; Jaime K Brown; James M Gold; James A Waltz
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-12-07

8.  Relationship between effortful motivation and neurocognition in schizophrenia.

Authors:  Andrew W Bismark; Michael L Thomas; Melissa Tarasenko; Alexandra L Shiluk; Sonia Y Rackelmann; Jared W Young; Gregory A Light
Journal:  Schizophr Res       Date:  2017-06-30       Impact factor: 4.939

9.  Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.

Authors:  Danielle A Schlosser; Timothy R Campellone; Bruno Biagianti; Kevin L Delucchi; David E Gard; Daniel Fulford; Barbara K Stuart; Melissa Fisher; Rachel L Loewy; Sophia Vinogradov
Journal:  Schizophr Res       Date:  2015-10-31       Impact factor: 4.939

10.  Prospective Relationships Between Motivation and Functioning in Recovery After a First Episode of Schizophrenia.

Authors:  Daniel Fulford; Danijela Piskulic; Jean Addington; John M Kane; Nina R Schooler; Kim T Mueser
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.